Form 4 · Filed May 5, 2026, 12:37 PM UTC
AVLN/Avalyn Pharma Inc.
FMR LLC — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
10 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | C | other | 727,585 | — | — | 727,585 |
| May 1, 2026 | C | other | 80,291 | — | — | 807,876 |
| May 1, 2026 | C | other | 872,868 | — | — | 1,680,744 |
| May 1, 2026 | C | other | 225,843 | — | — | 1,906,587 |
| May 1, 2026 | C | other | 377,948 | — | — | 2,284,535 |
| May 1, 2026 | C | other | 727,585 | — | — | 0 |
| May 1, 2026 | C | other | 80,291 | — | — | 0 |
| May 1, 2026 | C | other | 872,868 | — | — | 0 |
| May 1, 2026 | C | other | 225,843 | — | — | 0 |
| May 1, 2026 | C | other | 377,948 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-205201